FDA Approves Vibativ (Telavancin) For Bacterial Pneumonia
Vibativ (telavancin) has been approved by the FDA to treat HABP/VABP (hospital-acquired ventilator-associated bacterial pneumonia) caused by Staphylococcus aureus. The
Source: Health News
Posted in: AICHC News
Leave a Comment (0) ↓